These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16296724)

  • 21. Pharmacokinetics of plasmid DNA-based non-viral gene medicine.
    Nishikawa M; Takakura Y; Hashida M
    Adv Genet; 2005; 53():47-68. PubMed ID: 16240990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.
    Takahashi Y; Nishikawa M; Takakura Y
    Front Biosci (Schol Ed); 2012 Jan; 4(1):133-41. PubMed ID: 22202048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular uptake and activation characteristics of naked plasmid DNA and its cationic liposome complex in human macrophages.
    Yamane I; Nishikawa M; Takakura Y
    Int J Pharm; 2005 Nov; 305(1-2):145-53. PubMed ID: 16219432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
    Pringle IA; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of plasmid DNA preparations contaminated with bacterial genomic DNA on inflammatory responses following delivery of lipoplexes to the murine lung.
    Bazzani RP; Cai Y; Hebel HL; Hyde SC; Gill DR
    Biomaterials; 2011 Dec; 32(36):9854-65. PubMed ID: 21944469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing plasmid vectors.
    Tolmachov O
    Methods Mol Biol; 2009; 542():117-29. PubMed ID: 19565899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmethylated CpG motifs mimicking bacterial DNA triggers the local and systemic innate immune parameters and expression of immune-relevant genes in gilthead seabream.
    Cuesta A; Salinas I; Esteban MA; Meseguer J
    Fish Shellfish Immunol; 2008 Nov; 25(5):617-24. PubMed ID: 18824235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-viral is superior to viral gene delivery.
    Li SD; Huang L
    J Control Release; 2007 Nov; 123(3):181-3. PubMed ID: 17935817
    [No Abstract]   [Full Text] [Related]  

  • 30. [Naked DNA and lipoplexes applications in cancer gene therapy].
    Bertin S; Neves S; Pedroso de Lima M; Pierrefite-Carle V
    Bull Cancer; 2007 Mar; 94(3):243-52. PubMed ID: 17371766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of peptide motifs for potent non-viral gene delivery highly selective for dividing cells.
    Parker AL; Collins L; Zhang X; Fabre JW
    J Gene Med; 2005 Dec; 7(12):1545-54. PubMed ID: 16037993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy. Safer and virus-free?
    Ferber D
    Science; 2001 Nov; 294(5547):1638-42. PubMed ID: 11721029
    [No Abstract]   [Full Text] [Related]  

  • 33. Challenges and strategies: the immune responses in gene therapy.
    Zhou HS; Liu DP; Liang CC
    Med Res Rev; 2004 Nov; 24(6):748-61. PubMed ID: 15250039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro.
    Shen Y; Peng H; Deng J; Wen Y; Luo X; Pan S; Wu C; Feng M
    Int J Pharm; 2009 Jun; 375(1-2):140-7. PubMed ID: 19442462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
    Reyes-Sandoval A; Ertl HC
    Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
    Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
    J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors.
    Zhao H; Hemmi H; Akira S; Cheng SH; Scheule RK; Yew NS
    Mol Ther; 2004 Feb; 9(2):241-8. PubMed ID: 14759808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of Cationic Lipid-DNA Complexes.
    Yew NS; Scheule RK
    Adv Genet; 2005; 53PA():189-214. PubMed ID: 16243064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.
    Karmali PP; Chaudhuri A
    Med Res Rev; 2007 Sep; 27(5):696-722. PubMed ID: 17022036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.